The PLAC Test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme linked to inflammation within the walls of blood vessels. Elevated Lp-PLA2 levels are associated with increased risk of cardiovascular events, such as heart attack and stroke, independent of traditional cholesterol levels.
This test is commonly used as an advanced cardiovascular risk marker, particularly in individuals with existing heart disease risk factors, a family history of cardiovascular disease, or inconclusive results from standard lipid testing. Results help identify vascular inflammation and support more personalized cardiovascular risk assessment and prevention strategies.
PLAC TEST (Lp-PLA2)
The PLAC Test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme linked to inflammation within the walls of blood vessels. Elevated Lp-PLA2 levels are associated with increased risk of cardiovascular events, such as heart attack and stroke, independent of traditional cholesterol levels.
This test is commonly used as an advanced cardiovascular risk marker, particularly in individuals with existing heart disease risk factors, a family history of cardiovascular disease, or inconclusive results from standard lipid testing. Results help identify vascular inflammation and support more personalized cardiovascular risk assessment and prevention strategies.
